Our findings showed that most of DNA methylation sites associated with SARDH in HCC were hypermethylated, and patients with SARDH hypermethylation had a lower OS compared to those with SARDH hypomethylation (Figure 6A). The gene discussed is SARDH; the disease is hepatocellular carcinoma.